Gujarat Terce Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, sales was INR 479.75 million compared to INR 467.83 million a year ago. Revenue was INR 482.96 million compared to INR 471.37 million a year ago. Net income was INR 2.43 million compared to net loss of INR 16.72 million a year ago. Basic earnings per share from continuing operations was INR 0.33 compared to basic loss per share from continuing operations of INR 2.25 a year ago. Diluted earnings per share from continuing operations was INR 0.33 compared to diluted loss per share from continuing operations of INR 2.25 a year ago.